<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on May 29, 2018</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT01052285</url>
  </required_header>
  <id_info>
    <org_study_id>SM1-plp-10</org_study_id>
    <secondary_id>2010-018403-29</secondary_id>
    <nct_id>NCT01052285</nct_id>
  </id_info>
  <brief_title>The Efficacy of Transversus Abdominis Plane Block After Groin Hernia Repair</brief_title>
  <official_title>The Efficacy of Transversus Abdominis Plane Block Versus Placebo Versus Local Infiltration in Patients Undergoing Groin Hernia Repair in Day Case Surgery.</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Glostrup University Hospital, Copenhagen</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>Glostrup University Hospital, Copenhagen</source>
  <oversight_info>
    <has_dmc>Yes</has_dmc>
  </oversight_info>
  <brief_summary>
    <textblock>
      The purpose of this study is to determine whether Transversus abdominis plane block is
      superior to placebo or superior to local infiltration in analgesic efficacy after groin
      hernia repair.
    </textblock>
  </brief_summary>
  <overall_status>Completed</overall_status>
  <start_date>June 2010</start_date>
  <completion_date type="Actual">November 2011</completion_date>
  <primary_completion_date type="Actual">November 2011</primary_completion_date>
  <phase>Phase 4</phase>
  <study_type>Interventional</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <allocation>Randomized</allocation>
    <intervention_model>Parallel Assignment</intervention_model>
    <primary_purpose>Treatment</primary_purpose>
    <masking>Quadruple (Participant, Care Provider, Investigator, Outcomes Assessor)</masking>
  </study_design_info>
  <primary_outcome>
    <measure>Pain scores by coughing between TAP block group and placebo group</measure>
    <time_frame>0,2,4,6,8,19 and 24 hours postoperative</time_frame>
    <description>Area under the curve (AUC)-pain during cough based on measurements at 0,2,4,6,8,19,24 hours postoperative</description>
  </primary_outcome>
  <secondary_outcome>
    <measure>Pain scores by coughing between placebo and local infiltration and between TAP block and local infiltration.</measure>
    <time_frame>0,2,4,6,8,19 and 24 hours postoperative</time_frame>
    <description>Area under the curve (AUC)-pain during cough based on measurements 0,2,4,6,8,19,24 hours postoperative.</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Total opioid consumption</measure>
    <time_frame>0-24 hours postoperative</time_frame>
    <description>Total morphine consumption 0-2 hours postoperative. Total ketobemidone consumption 2-24 hours postoperative.</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Postoperative nausea and vomiting</measure>
    <time_frame>0,2,4,6,8,19,24 hours postoperative</time_frame>
    <description>Levels of nausea (0-3)at 0,2,4,6,8,19,24 hours postoperative Number of vomits 0-2, 2-4, 4-6, 6-8, 8-19 og 19-24 hours postoperative.</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Sedation</measure>
    <time_frame>0,2,4,6,8,19,24 hours postoperative</time_frame>
    <description>Levels of sedation (0-3)at 0,2,4,6,8,19,24 hours postoperative.</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Pain scores at rest between TAP block versus placebo and TAP block versus infiltration and infiltration versus placebo</measure>
    <time_frame>0,2,4,6,8,19,24 hours postoperative</time_frame>
    <description>Area under the curve (AUC)-pain at rest based on measurements at 0,2,4,6,8,19,24 hours postoperative</description>
  </secondary_outcome>
  <number_of_arms>3</number_of_arms>
  <enrollment type="Actual">90</enrollment>
  <condition>Hernia</condition>
  <arm_group>
    <arm_group_label>Placebo</arm_group_label>
    <arm_group_type>Placebo Comparator</arm_group_type>
    <description>TAP block with 25 ml of saline Ilioinguinal block with 10 ml of saline and local infiltration with 40 ml of saline.</description>
  </arm_group>
  <arm_group>
    <arm_group_label>Local infiltration</arm_group_label>
    <arm_group_type>Active Comparator</arm_group_type>
    <description>Ilioinguinal block with 10 ml of ropivacaine 0,375% Local infiltration with 40 ml of ropivacaine 0,375% Tap block with 25 ml of saline</description>
  </arm_group>
  <arm_group>
    <arm_group_label>Transversus abdominis plane block</arm_group_label>
    <arm_group_type>Experimental</arm_group_type>
    <description>25 ml of Ropivacaine 0,75%, Ilioinguinal block with 10 ml saline and local infiltration with 40 ml of saline.</description>
  </arm_group>
  <intervention>
    <intervention_type>Procedure</intervention_type>
    <intervention_name>Transversus abdominis plane block</intervention_name>
    <description>UL-guided TAP block with 25 ml of ropivacaine 0,75% unilateral, single dose, ilioinguinal block with 10 ml of saline and local infiltration with 40 ml of saline</description>
    <arm_group_label>Transversus abdominis plane block</arm_group_label>
    <other_name>postoperative pain, UL-guided block</other_name>
  </intervention>
  <intervention>
    <intervention_type>Procedure</intervention_type>
    <intervention_name>Saline</intervention_name>
    <description>UL-guided Tap block with 25 ml of saline single dose Ilioinguinal block with 10 ml of saline and local infiltration with saline 40 ml single dose</description>
    <arm_group_label>Placebo</arm_group_label>
    <other_name>postoperative pain.</other_name>
  </intervention>
  <intervention>
    <intervention_type>Procedure</intervention_type>
    <intervention_name>Local infiltration</intervention_name>
    <description>Ilioinguinal block with 10 ml of ropivacaine 0,375% single dose, local infiltration with 40 ml of ropivacaine 0,375% single dose, UL-guided Tap block with 25 ml of saline single dose</description>
    <arm_group_label>Local infiltration</arm_group_label>
    <other_name>Local wound infiltration</other_name>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:

          -  18-75 years old

          -  groin hernia repair

          -  written consent

          -  ASA 1-3

          -  BMI 18-35

        Exclusion Criteria:

          -  unable to communicate in Danish

          -  relevant drug allergy

          -  pain medication in the last 24 hours

          -  pregnancy

          -  alcohol or/and drug abuse

          -  daily opioid intake

          -  infection at injection site
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>18 Years</minimum_age>
    <maximum_age>75 Years</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>Pernille L Petersen, MD</last_name>
    <role>Principal Investigator</role>
    <affiliation>Glostrup University Hospital</affiliation>
  </overall_official>
  <location>
    <facility>
      <name>Department of Anaesthesiology, Glostrup university hospital</name>
      <address>
        <city>Glostrup</city>
        <zip>2600</zip>
        <country>Denmark</country>
      </address>
    </facility>
  </location>
  <location_countries>
    <country>Denmark</country>
  </location_countries>
  <verification_date>November 2011</verification_date>
  <!-- For several months we've had both old and new date name tags                             -->
  <!-- Now, the old date names have been dropped.                                               -->
  <!-- The new date name replacements are:                                                      -->
  <!--     OLD (gone)                                        NEW (in use)                       -->
  <!--   lastchanged_date                         becomes   last_update_submitted               -->
  <!--   firstreceived_date                       becomes   study_first_submitted               -->
  <!--   firstreceived_results_date               becomes   results_first_submitted             -->
  <!--   firstreceived_results_disposition_date   becomes   disposition_first_submitted         -->
  <study_first_submitted>January 19, 2010</study_first_submitted>
  <study_first_submitted_qc>January 19, 2010</study_first_submitted_qc>
  <study_first_posted type="Estimate">January 20, 2010</study_first_posted>
  <last_update_submitted>November 17, 2011</last_update_submitted>
  <last_update_submitted_qc>November 17, 2011</last_update_submitted_qc>
  <last_update_posted type="Estimate">November 18, 2011</last_update_posted>
  <responsible_party>
    <responsible_party_type>Principal Investigator</responsible_party_type>
    <investigator_affiliation>Glostrup University Hospital, Copenhagen</investigator_affiliation>
    <investigator_full_name>Pernille Lykke Petersen</investigator_full_name>
    <investigator_title>MD</investigator_title>
  </responsible_party>
  <keyword>Transversus abdominis plane block</keyword>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Hernia</mesh_term>
  </condition_browse>
  <intervention_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Ropivacaine</mesh_term>
  </intervention_browse>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

